MyFinsight
Home
Blog
About
Back
Cash Flow
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
source: myfinsight.com
Proceeds from issuance of
shares for private...
$1,023K
Net cash provided by
financing activities
$898K
(-84.48%↓ Y/Y)
Canceled cashflow
$125K
Increase (decrease) in
cash and cash...
$3K
(-99.54%↓ Y/Y)
Canceled cashflow
$895K
Proceeds from short-term
loans (note 6)
-$125K
(37.19%↑ Y/Y)
Stock-based compensation
related to options...
$2,244K
(83.93%↑ Y/Y)
Increase (decrease) in
employees related...
$564K
Increase in accounts
payable
$171K
Increase in interest
expense
$57K
Depreciation
$46K
(-55.34%↓ Y/Y)
Change in operating
lease liability
$5K
(-92.65%↓ Y/Y)
Net cash used in
operating activities
-$895K
(82.56%↑ Y/Y)
Canceled cashflow
$3,087K
Net loss
-$3,855K
(33.15%↑ Y/Y)
Decrease in other
accounts receivable and...
$127K
(-74.34%↓ Y/Y)
Back